ALLSCRIPTS HEALTHCARE SOLUTN (MDRX)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
2
Reporting holders
$71
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | $66 | 13,000 | 0.02% | 7q | HELD |
| HUNTINGTON NATIONAL BANK | $5 | 1 | 0.00% | 10q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2 | $71 | 13,001 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 2 | $65 | 13,001 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $67 | 13,001 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 3 | $240 | 48,979 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 3 | $236 | 48,979 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 4 | $145.3K | 82,259 | 0 | 1 | 0 | 0.0% |
| Q4 2024 | 6 | $25.3M | 2,598,654 | 1 | 0 | 3 | 0.0% |
| Q3 2024 | 7 | $49.8M | 5,131,778 | 1 | 1 | 2 | 0.0% |
| Q2 2024 | 9 | $34.5M | 3,635,512 | 2 | 0 | 5 | 0.0% |
| Q1 2024 | 29 | $91.1M | 11,829,115 | 10 | 4 | 7 | 0.0% |
| Q4 2023 | 201 | $1.2B | 111,495,568 | 39 | 60 | 64 | 3.6% |
| Q3 2023 | 188 | $1.4B | 107,869,773 | 19 | 54 | 70 | 1.0% |
| Q2 2023 | 196 | $1.4B | 107,419,728 | 21 | 71 | 64 | 0.3% |
| Q1 2023 | 203 | $1.4B | 104,743,939 | 28 | 66 | 74 | 0.2% |
| Q4 2022 | 193 | $1.4B | 82,062,537 | 34 | 47 | 73 | 0.1% |
| Q3 2022 | 249 | $1.8B | 117,397,361 | 35 | 91 | 81 | 0.3% |
| Q2 2022 | 241 | $1.7B | 116,210,417 | 30 | 60 | 101 | 0.3% |
| Q1 2022 | 251 | $2.7B | 120,405,857 | 62 | 69 | 72 | 0.1% |
| Q4 2021 | 215 | $2.3B | 122,981,999 | 24 | 36 | 96 | 0.2% |
| Q3 2021 | 217 | $1.7B | 128,691,960 | 23 | 47 | 95 | 0.2% |
| Q2 2021 | 232 | $2.6B | 137,665,142 | 28 | 55 | 98 | 0.6% |
| Q1 2021 | 234 | $2.2B | 145,627,672 | 41 | 52 | 93 | 0.4% |
| Q4 2020 | 220 | $2.2B | 153,866,585 | 40 | 36 | 89 | 0.5% |
| Q3 2020 | 202 | $1.3B | 164,883,755 | 29 | 43 | 78 | 0.1% |
| Q2 2020 | 198 | $1.2B | 174,342,911 | 32 | 64 | 59 | 0.1% |
| Q1 2020 | 201 | $1.2B | 174,437,682 | 22 | 57 | 70 | 0.1% |
| Q4 2019 | 236 | $1.8B | 186,344,890 | 43 | 64 | 78 | 0.2% |
| Q3 2019 | 213 | $2.0B | 177,504,294 | 23 | 66 | 81 | 0.5% |
| Q2 2019 | 222 | $2.1B | 181,621,247 | 29 | 66 | 88 | 0.6% |
| Q1 2019 | 226 | $1.7B | 175,837,602 | 35 | 71 | 76 | 0.1% |
| Q4 2018 | 223 | $1.8B | 182,150,877 | 5 | 2 | 3 | 0.2% |